Arkolith/Insider Trading/CMPX/Form 4

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER, DirectorCompass Therapeutics, Inc. (CMPX) · full profile →Form 4 · filed Nov 21, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2023Tax withholding(F)44K$1.50$66K6.0M

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-23-007222) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML